FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Trump’s $1 billion presidential library expected to dwarf all predecessors

‘Local independent’ outlet in Virginia pushing redistricting is owned by Democratic operatives

VP Vance to meet with Viktor Orbán in Hungary days ahead of foreign nation’s elections

Celebrity chef lashes out at Trump for changing the ‘rules’ the same year as America 250

Colorado House advances conversion therapy lawsuit bill; GOP lawmaker calls it ‘slap in the face’ to SCOTUS

Artemis II crew describes life aboard Orion spacecraft on historic journey to the moon and back

Erika Kirk and Karoline Leavitt talk free thinking and faith at TPUSA college tour kickoff

Karoline Leavitt reveals ‘anti-climatic’ way Trump told her she’d be press secretary: ‘Oh, by the way’

Trump slaps up to 100% tariff on some brand-name drug imports in major America First push

Two arrested in NC after police find 13-year-old kept in dog kennel, 5 other kids in ‘filthy’ home

Heart-pounding video shows fisherman leaping into ocean to save great white shark

Pete Hegseth signs memo opening door for troops to carry personal firearms on bases

Illegal migrant babysitter accused in 5-year-old attack now faces major charges

Florida, Mississippi join wave of states tightening voter citizenship rules

Trump Announces Plan to Help DHS Workers in Spite of ‘Radical Left’ Shutdown

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”